Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UK Expects…The AAR Innovation Review To Be More Than A Few Silver Bullets

This article was originally published in Clinica

Executive Summary

Enthusiasm surrounding the UK’s Accelerated Access Review (AAR), a program to speed innovative drugs, devices, diagnostics and digital products into usage in NHS England, was brought to a crescendo in early September. That was when AAR expert on medtech and external advisory group member John Jeans exhorted full participation in the online consultation on the AAR website.